从“跟跑”到“领跑”！成都核医疗产业崛起迎“聚变”式发展

Core Insights - The "World Fusion Energy Group" held its second ministerial meeting and the 30th International Conference on Fusion Energy in Chengdu, where Sichuan province announced 24 policy measures to promote the high-quality development of the nuclear medicine industry [1][12] - Chengdu is positioning itself as a leader in the nuclear medicine sector, focusing on the entire industry chain from the production of medical isotopes to the development of radiopharmaceuticals and manufacturing of nuclear medical equipment [3][6] Policy Measures - Sichuan's new policies aim to support precise targeting, industrial upgrades, expanding application demands, and creating a favorable development environment [1] - The release of an opportunity list in the nuclear medicine sector highlights Chengdu's commitment to developing three nuclear drug bases [1] Industry Developments - Chengdu's nuclear medicine sector has seen significant advancements, including the clinical approval of innovative nuclear drugs and substantial financing for nuclear medicine companies [3][4][12] - The establishment of the Fosun Pharma nuclear drug platform in Chengdu marks a strategic move to enhance research and development in the nuclear medicine field [9][10] Innovation and Breakthroughs - Chengdu's Baile Tianheng received approval for its first antibody-radiolabeled drug, which is expected to significantly improve treatment for advanced or metastatic solid tumors [4] - The successful development and export of a domestically produced germanium-gallium generator by Chengdu's Nureter Medical Technology represents a breakthrough in the self-sufficiency of medical isotopes [5] Ecosystem and Collaboration - Chengdu is fostering a collaborative ecosystem that integrates policy support, capital investment, talent attraction, and industry-academia cooperation to enhance the nuclear medicine industry [12][13] - The establishment of specialized parks and research centers in Chengdu is aimed at creating a comprehensive support system for nuclear medicine innovation [11][14]